Evidence map›Paper›PMID 25990747›Full record

ArticleArthritis research & therapy2015

Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis.

Heidi Kokkonen, Mikael Brink, Monika Hansson, Ewa Lassen, Linda Mathsson-Alm, Rikard Holmdahl, Johan Rönnelid, Lars Klareskog, Solbritt Rantapää-Dahlqvist

Abstract read
In one paragraph

Article in Arthritis research & therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Article
  9. Pre-RA: Can early diagnosis lead to prevention?Best practice & research. Clinical rheumatology · 2022
    Review
  10. Article
  11. Article
  12. Review
  13. [Strong inflammation is essential for expression of articular cartilage-specific citrullinated antigens].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2020
    Article
  14. Obstructive lung diseases and risk of rheumatoid arthritis.Expert review of clinical immunology · 2020
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Heidi KokkonenInstitution of Public Health and Clinical Medicine/Rheumatolgy, Umeå University, SE-90185, Umeå, Sweden. heidi.kokkonen@umu.se.
Mikael BrinkInstitution of Public Health and Clinical Medicine/Rheumatolgy, Umeå University, SE-90185, Umeå, Sweden. mikael.brink@medicin.umu.se.
Monika HanssonRheumatology Unit, Karolinska University Hospital, Stockholm, Sweden. monika.hansson@ki.se.
Ewa LassenInstitution of Public Health and Clinical Medicine/Rheumatolgy, Umeå University, SE-90185, Umeå, Sweden. ewa.lassen@vll.se.
Linda Mathsson-AlmDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. linda.mathsson-alm@thermofisher.com.
Rikard HolmdahlMedical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden. rikard.holmdahl@ki.se.
Johan RönnelidDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. johan.ronnelid@igp.uu.se.
Lars KlareskogRheumatology Unit, Karolinska University Hospital, Stockholm, Sweden. lars.klareskog@ki.se.
Solbritt Rantapää-DahlqvistInstitution of Public Health and Clinical Medicine/Rheumatolgy, Umeå University, SE-90185, Umeå, Sweden. solbritt.rantapaa.dahlqvist@umu.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIt has previously been shown that an increased number of antibodies against citrullinated peptides/proteins (ACPA) predate the onset of rheumatoid arthritis (RA). Over time antibody positivity expands, involving more specific responses when approaching the onset of symptoms. We investigated the impact of human leukocyte antigen-shared epitope (HLA-SE) alleles and smoking on the development of ACPA, as well as in combination with ACPA during the state of quiescent autoimmunity (before the onset of symptoms), on the development of RA.

methodsBlood samples donated to the Medical Biobank of Northern Sweden from individuals prior to the onset of symptoms of RA (n=370) and after onset (n=203) and from population-based controls (n=585) were used. Antibodies against 10 citrullinated peptides, fibrinogen (Fibα561-583, α580-600, ß62-81a, ß62-81b, ß36-52), vimentin (Vim2-17, 60-75), filaggrin (CCP-1/Fil307-324), α-enolase (CEP-1/Eno5-21), collagen type II (citC1359-369), and anti-cyclic citrullinated peptide (CCP)2 antibodies were analysed.

resultsHLA-SE-positive individuals were more frequently positive for ACPA compared with HLA-SE-negative individuals prior to the onset of symptoms of RA, particularly for antibodies against CEP-1 and Fibß62-81a (72). Smoking was associated with antibodies against Vim2-17 and citC1359-369. HLA-SE and smoking showed increasing association to the presence of the antibodies closer to disease onset. The highest odds ratio (OR) for development of RA was for the combination of HLA-SE alleles and ACPA positivity, especially for antibodies against Fibß62-81b, CCP-1/Fil307-324, and Fibβ36-52. A gene-environment additive interaction between smoking and HLA-SE alleles for the risk of disease development was found, with the highest OR for individuals positive for antibodies against Fibβ36-52, CEP-1, and Fibα580-600.

conclusionsThe relationships between antibodies against the different ACPA specificities, HLA-SE, and smoking showed a variable pattern in individuals prior to the onset of RA. The combination of smoking and HLA-SE alleles was significantly associated with the development of some of the antibody specificities closer to onset of symptoms, and these associations remained significant at diagnosis. An additive gene-environment interaction was found for several of the antibodies for the development of RA.

Indexed as

Arthritis, RheumatoidAutoantibodiesFemaleFilaggrin ProteinsHLA AntigensHumansMaleMiddle AgedPeptides, CyclicRetrospective StudiesSmokingAutoantibodiescyclic citrullinated peptideFilaggrin ProteinsFLG protein, humanHLA AntigensPeptides, Cyclic

Identifiers

PMID25990747
PMCPMC4438519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.